Zebisch A - Search Results

1

Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations.

Zebisch A, Haller M, Hiden K, Goebel T, Hoefler G, Troppmair J, Sill H. Zebisch A, et al. Leukemia. 2009 Jun;23(6):1049-53. doi: 10.1038/leu.2009.68. Epub 2009 Apr 9. Leukemia. 2009. PMID: 19357705

2

Therapy-related leukemia cutis: case study of an aggressive disorder.

Zebisch A, Cerroni L, Beham-Schmid C, Sill H. Zebisch A, et al. Ann Hematol. 2003 Nov;82(11):705-7. doi: 10.1007/s00277-003-0717-y. Epub 2003 Aug 14. Ann Hematol. 2003. PMID: 12920571

3

High expression of the sister-chromatid separation regulator and proto-oncogene hSecurin occurs in a subset of myeloid leukaemias but is not implicated in the pathogenesis of aneuploidy.

Auner HW, Zebisch A, Schimek MG, Bodner C, Hiden K, Linkesch W, Haas OA, Beham-Schmid C, Sill H. Auner HW, et al. Among authors: zebisch a. Leukemia. 2004 Feb;18(2):303-8. doi: 10.1038/sj.leu.2403235. Leukemia. 2004. PMID: 14671639

4

Bedside RNA stabilizing kit systems for gene expression analysis of acute leukemias: influence of non-neoplastic white blood cells.

Zebisch A, Linkesch W, Sill H. Zebisch A, et al. Leukemia. 2005 Jan;19(1):136-7. doi: 10.1038/sj.leu.2403581. Leukemia. 2005. PMID: 15510197 No abstract available.

5

Evaluation of potential risk factors for early infectious complications after autologous peripheral blood stem cell transplantation in patients with lymphoproliferative diseases.

Auner HW, Zebisch A, Ofner P, Sill H, Linkesch W, Krause R. Auner HW, et al. Among authors: zebisch a. Ann Hematol. 2005 Aug;84(8):532-7. doi: 10.1007/s00277-005-1025-5. Epub 2005 Apr 5. Ann Hematol. 2005. PMID: 15809882

6

Bedside RNA stabilizing kit systems for gene expression analysis of acute leukemias: influence of non-neoplastic white blood cells.

Zebisch A, Linkesch W, Sill H. Zebisch A, et al. Leukemia. 2005 Apr;19(4):685. doi: 10.1038/sj.leu.2403713. Leukemia. 2005. PMID: 15861178 No abstract available.

7

Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia.

Zebisch A, Staber PB, Delavar A, Bodner C, Hiden K, Fischereder K, Janakiraman M, Linkesch W, Auner HW, Emberger W, Windpassinger C, Schimek MG, Hoefler G, Troppmair J, Sill H. Zebisch A, et al. Cancer Res. 2006 Apr 1;66(7):3401-8. doi: 10.1158/0008-5472.CAN-05-0115. Cancer Res. 2006. PMID: 16585161

8

Back to the roots: the remarkable RAF oncogene story.

Zebisch A, Troppmair J. Zebisch A, et al. Cell Mol Life Sci. 2006 Jun;63(11):1314-30. doi: 10.1007/s00018-006-6005-y. Cell Mol Life Sci. 2006. PMID: 16649144 Free PMC article. Review.

9

Signaling through RAS-RAF-MEK-ERK: from basics to bedside.

Zebisch A, Czernilofsky AP, Keri G, Smigelskaite J, Sill H, Troppmair J. Zebisch A, et al. Curr Med Chem. 2007;14(5):601-23. doi: 10.2174/092986707780059670. Curr Med Chem. 2007. PMID: 17346150 Review.

10

Are mouthwashes a reliable source of constitutional DNA in patients with leukemia?

Zebisch A, Sill H. Zebisch A, et al. Leuk Res. 2008 Jul;32(7):1164-5. doi: 10.1016/j.leukres.2007.11.003. Epub 2007 Dec 21. Leuk Res. 2008. PMID: 18082258 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters